Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.B1 (
angiotensin-converting enzyme 2
)
1,025
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
Nrf2
-Keap1-ARE pathway is the principal regulator of antioxidant and phase II detoxification genes. Its activation increases the expression of antioxidant and cytoprotective proteins, protecting cells against infections.
Nrf2
modulates virus-induced oxidative stress, ROS generation, and disease pathogenesis, which are vital in the viral life cycle. During respiratory viral infections, such as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an inflammatory process, and oxidative stress of the epithelium lining cells activate the transcription factor
Nrf2
, which protects cells from oxidative stress and inflammation.
Nrf2
reduces
angiotensin-converting enzyme 2
(
ACE2
) receptors expression in respiratory epithelial cells. SARS-CoV2 has a high affinity for
ACE2
that works as receptors for coronavirus surface spike glycoprotein, facilitating viral entry. Disease severity may also be modulated by pre-existing conditions, such as impaired immune response, obesity, and age, where decreased level of
Nrf2
is a common feature. Consequently,
Nrf2
activators may increase
Nrf2
levels and enhance antiviral mediators' expression, which could initiate an "antiviral state", priming cells against viral infection. Therefore, this hypothesis paper describes the use of flavonoid supplements combined with vitamin D3 to activate
Nrf2
, which may be a potential target to prevent and/or decrease SARS-CoV-2 infection severity, reducing oxidative stress and inflammation, enhancing innate immunity, and downregulating
ACE2
receptors.
...
PMID:Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity. 3272 64
Large differences in COVID-19 death rates exist between countries and between regions of the same country. Some very low death rate countries such as Eastern Asia, Central Europe, or the Balkans have a common feature of eating large quantities of fermented foods. Although biases exist when examining ecological studies, fermented vegetables or cabbage have been associated with low death rates in European countries. SARS-CoV-2 binds to its receptor, the
angiotensin-converting enzyme 2
(
ACE2
). As a result of SARS-CoV-2 binding,
ACE2
downregulation enhances the angiotensin II receptor type 1 (AT
1
R) axis associated with oxidative stress. This leads to insulin resistance as well as lung and endothelial damage, two severe outcomes of COVID-19. The nuclear factor (erythroid-derived 2)-like 2 (
Nrf2
) is the most potent antioxidant in humans and can block in particular the AT
1
R axis. Cabbage contains precursors of sulforaphane, the most active natural activator of
Nrf2
. Fermented vegetables contain many lactobacilli, which are also potent
Nrf2
activators. Three examples are: kimchi in Korea, westernized foods, and the slum paradox. It is proposed that fermented cabbage is a proof-of-concept of dietary manipulations that may enhance
Nrf2
-associated antioxidant effects, helpful in mitigating COVID-19 severity.
...
PMID:Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19. 3276 35
We investigated the mechanism by which ACE2 (
angiotensin-converting enzyme 2
) overexpression alters neurohumoral outflow and central oxidative stress.
Nrf2
(nuclear factor [erythroid-derived 2]-like 2) is a master antioxidant transcription factor that regulates cytoprotective and antioxidant genes. We hypothesized that upregulation of central ACE2 inhibits the pressor response to Ang II (angiotensin II) by reducing reactive oxygen species through a
Nrf2
/antioxidant enzyme-mediated mechanism in the rostral ventrolateral medulla. Synapsin human Angiotensin Converting Enzyme 2 positive (SynhACE2
+/+
) mice and their littermate controls synhACE2
-/-
were used to evaluate the consequence of intracerebroventricular infusion of Ang II. In control mice, Ang II infusion evoked a significant increase in blood pressure and norepinephrine excretion, along with polydipsia and polyuria. The pressor effect of central Ang II was completely blocked in synhACE2
+/+
mice. Polydipsia, norepinephrine excretion, and markers of oxidative stress in response to central Ang II were also reduced in synhACE2
+/+
mice. The MasR (Mas receptor) agonist Ang 1-7 and blocker A779 had no effects on blood pressure. synhACE2
+/+
mice showed enhanced expression of
Nrf2
in the rostral ventrolateral medulla which was blunted following Ang II infusion. Ang II evoked nuclear translocation of
Nrf2
in cultured Neuro 2A (N2A) cells. In synhACE2
-/-
mice, the central Ang II pressor response was attenuated by simultaneous intracerebroventricular infusion of the
Nrf2
activator sulforaphane; blood pressure was enhanced by knockdown of
Nrf2
in the rostral ventrolateral medulla in
Nrf2
floxed (
Nrf2
f/f
) mice. These data suggest that the hypertensive effects of intracerebroventricular Ang II are attenuated by selective overexpression of brain synhACE2 and may be mediated by
Nrf2
-upregulated antioxidant enzymes in the rostral ventrolateral medulla.
...
PMID:Overexpression of Central ACE2 (Angiotensin-Converting Enzyme 2) Attenuates the Pressor Response to Chronic Central Infusion of Ang II (Angiotensin II): A Potential Role for Nrf2 (Nuclear Factor [Erythroid-Derived 2]-Like 2). 3289 18